FDA recall, , Moderate risk
American National Red Cross Apheresis Platelets
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced were possibly exposed to unacceptable temperatures due to extended transit time.
Recall ended Sep 8, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross South Carolina Region recalled Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced because the product was possibly exposed to unacceptable temperatures due to extended transit time. The recall began on March 19, 2025, and the product was distributed in Michigan and South Carolina.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced
- Affected units
- W18172585411100M (triple collection); W181725855524001 (triple collection); W181725854885004; W18172585552500*; W183225873755007 (double collection); W18172585551900W (double collection)
Recall details
- Company began the recall
- Sold in
- Company
- The American National Red Cross South Carolina Region
- Hazard
- Processing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99502
- Recall number
- B-0233-2026
All recalls from The American National Red Cross South Carolina Region
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
